A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
Open Access
- 19 October 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 21 (2), 97-107
- https://doi.org/10.1093/ijnp/pyx070
Abstract
Major depressive disorder is a common condition that often includes cognitive dysfunction. A systematic literature review of studies and a network meta-analysis were carried out to assess the relative effect of antidepressants on cognitive dysfunction in major depressive disorder. MEDLINE, Embase, Cochrane, CDSR, and PsychINFO databases; clinical trial registries; and relevant conference abstracts were searched for randomized controlled trials assessing the effects of antidepressants/placebo on cognition. A network meta-analysis comparing antidepressants was conducted using a random effects model. The database search retrieved 11337 citations, of which 72 randomized controlled trials from 103 publications met the inclusion criteria. The review identified 86 cognitive tests assessing the effect of antidepressants on cognitive functioning. However, the Digit Symbol Substitution Test, which targets multiple domains of cognition and is recognized as being sensitive to change, was the only test that was used across 12 of the included randomized controlled trials and that allowed the construction of a stable network suitable for the network meta-analysis. The interventions assessed included selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and other non-selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors. The network meta-analysis using the Digit Symbol Substitution Test showed that vortioxetine was the only antidepressant that improved cognitive dysfunction on the Digit Symbol Substitution Test vs placebo {standardized mean difference: 0.325 (95% CI = 0.120; 0.529, P=.009}. Compared with other antidepressants, vortioxetine was statistically more efficacious on the Digit Symbol Substitution Test vs escitalopram, nortriptyline, and the selective serotonin reuptake inhibitor and tricyclic antidepressant classes. This study highlighted the large variability in measures used to assess cognitive functioning. The findings on the Digit Symbol Substitution Test indicate differential effects of various antidepressants on improving cognitive function in patients with major depressive disorder.Keywords
Funding Information
- H. Lundbeck A/S and Takeda Pharmaceutical Company, Ltd
This publication has 36 references indexed in Scilit:
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010PLoS Medicine, 2013
- Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective studyPsychological Medicine, 2010
- The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?Schizophrenia Bulletin, 2010
- Cognitive impairment in major depressionEuropean Journal of Pharmacology, 2010
- The MMSE is not an adequate screening cognitive instrument in studies of late-life depressionJournal of Psychiatric Research, 2009
- Cognitive functioning in major depression – a summaryFrontiers in Human Neuroscience, 2009
- Prediction and prevention of suicide in patients with unipolar depression and anxietyAnnals of General Psychiatry, 2007
- Neuropsychological Impairment in Major Depression: Its Nature, Origin and Clinical SignificanceAustralian & New Zealand Journal of Psychiatry, 2007
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLoS Medicine, 2006
- Neuropsychological test profiles in schizophrenia and non‐psychotic depressionActa Psychiatrica Scandinavica, 2005